Electronic Health Records for research and Hospital management. The "Assistance Publique - Hôpitaux de Paris" initiative

Similar documents
Technical Agency for Information on Hospital Care

REPORT ON THE CIC: Centre d Investigation Clinique Intégré en Biothérapie (CIC-BT)

TRAINING NEEDS FOR CPP MEMBERS IN FRANCE

The Georges Pompidou University Hospital i2b2 Warehouse: learning and feedback from 8-years experience

Investment Opportunities in Lille-Region France

Recruiting emerging leaders in oncology Leaders de demain en oncologie

Pathophysiology of the visual system

Health Economics: Pharmaco-economic studies

The French National Research Agency (ANR)

Suggestions for Modification of the Clinical Trials Directive ELN Annual Meeting 01 February 2011

ASEM-DUO FELLOWSHIP PROGRAMME DUO/WALLONIA- BRUSSELS CALL FOR APPLICATIONS 2018

2018 call for proposals. Research projects in physics, mathematics or engineering sciences relating to Cancer

- RULES & REGULATIONS - Please read these rules and regulations and approve the general conditions for participating in the competition.

HCERES report on research unit: Under the supervision of the following institutions and research bodies:

EARLY ACCESS IN BELGIUM: STATUS UPDATE. Veerle Kempeneers & Rudy De Cock - Pfizer Kristel De Gauquier pharma.be

Health Care Careers 1

CaixaImpulse Form 2017

Submission of a clinical trial for access to ECRIN services Notice to the Applicant

Pharmacovigilance: The patient s Perspective. Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA

Retrospective Chart Review Studies

ACCREDITATION OF PHASE I UNITS AND PROTECTION OF THE SUBJECTS PARTICIPATING IN CLINICAL TRIALS IN FRANCE

Abstract submission regulations and instructions

Eligibility Criteria for NIHR Clinical Research Network Support

Labco. Consultation on healthcare mobility

As Director of Electrophysiology, I am happy that I studied hospital management in order to deal with my administrators

MAKE OUR PLANET GREAT AGAIN

France : Study & Discovery

PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR REVIEW/EVALUATION CLINICAL TRIAL APPLICATIONS FOR VACCINES AND BIOLOGICALS MALAWI

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

A WORLD-CLASS HIGHER EDUCATION AND RESEARCH ESTABLISHMENT

H ealthcare professionals assessments of the care provided

RULES AND REGULATIONS LARGE EQUIPMENT (GEQ) CALL 2018 ADOPTED BY THE BOARD OF TRUSTEES OF THE F.R.S.-FNRS

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES

National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

Managing Privacy Risk in Your Research and Development Enterprise. Sujata Dayal, Abbott Justin McCarthy, Pfizer

PAED-Net the German Network

ACCREDITATION MANUAL FOR HEALTH CARE ORGANISATIONS

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Facing biological interventions: coming back to the experience of firefighters of Paris. Pt2.

Annex VIIIA Guideline for correct preparation of a model patient information sheet and informed consent form (PIS/ICF)

2018 International Post-doctoral Program Applicant Guide

ASSESSMENT OF MEDICAL DEVICES

ERA-SPOT. Call Announcement 2009

PROSpect The PRone and OScillation Pediatric Clinical Trial

GRANT APPLICATION SCIENTIFIC ADVISORY BOARD OF THE JEROME LEJEUNE FOUNDATION

HOW TO MAKE YOUR RESEARCH MORE RELEVANT, FEASIBLE AND PUBLISHABLE PRELIMINARY PROGRAMME

2014 ACTIVITY REPORT 2014

End of year report Project. La Fondation Motrice

PFF Patient Registry Protocol Version 1.0 date 21 Jan 2016

Statistical Analysis of the EPIRARE Survey on Registries Data Elements

Application guidelines 1 for the Clinical Research (KLIF) programme

Mandatory accreditation of medical laboratories in France: how to best reconcile regulatory and normative requirements for cytogenetics?

4. Hospital and community pharmacies

Becoming a Data-Driven Organization: Journey to HIMSS EMRAM Stage 7

European Patients Academy (EUPATI) Update

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.

EUROCORES Programme European Collaborative Research. ECT Pan-European Clinical Trials.

Policy for Access to MINDACT Biological Materials and Data

European network of paediatric research (EnprEMA)

Standard Operating Procedures

to China 2 Visit of Philippe Busquin,Commissioner for Research of EC,

Kidney Cancer Association P.O. Box #38269 Chicago, IL Tel

CHARTER ON INFORMATION PROVIDED FOR THE PROMOTION OF MEDICINES THROUGH PROSPECTING AND CANVASSING

Master s Research Scholarship Programs

2016 Edition, third call. Call for proposals closing date. 23 February 2016 at 1 pm (Paris time) Call for proposals publication address

CANADIAN UROLOGICAL ASSOCIATION SCHOLARSHIP FUND BLADDER CANCER CANADA RESEARCH GRANT. Terms of Reference Background

PRC (Projets de Recherche Conjoints) (Joint Research Projects)

Variations in rates of appendicitis with peritonitis or peritoneal abscess in the context of reorganizing healthcare in Montreal-Centre

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Latin America: An Evolving Regulatory Environment September 15, Mapi 2015, All Rights Reserved

SMA Clinical Care Center Network / Clinical Data Registry & Clinical Trials Site Readiness for SMA. March 21, 2018

European Patients Academy on Therapeutic Innovation

biopsie chez l enfant

M6728. Goals. The Nuremberg Code. Ethics in Research Informed Consent/IRBs Reporting Research Results

Health care providers that undertake clinical research

Standard Operating Procedure (SOP) Research and Development Office

PRADO Post-hospitalization Home Return Assistance Programme A case of the National Sickness Insurance Fund for Employees

Asian Journal of Phytomedicine and Clinical Research Journal home page:

CNRST as a research operator and funding agency

Veterinary nursing and bioveterinary science Undergraduate

IT Volume 3 / Issue 1 - Winning Project

The 2011 edition of the NETVA program just launched!

Marie Skłodowska-Curie Actions

POSTGRADUATE DIPLOMA/MSc IN PHARMACEUTICAL MEDICINE

European Reference Networks: strategic value for the Member States. Perspective of France

Research Scholarship Programs Master

American College of Rheumatology Fellowship Curriculum

Role Profile Medical Officer- Medical Devices

European CRO Federation

Bill 59 (2012, chapter 23) An Act respecting the sharing of certain health information

Les inégalités de santé: Congres National des ORS

Bordeaux International Support National Taiwan University 1/5

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

Ethics Committee Composition Roles & Responsibilities. Dr Girish Dayma Dr Sanjay Juvekar KEM Hospital Research Centre Pune

Verification List. New Trial. XML (if not present, request to applicant) Receipt of confirmation of the EUDRACT number. Cover Letter.

CEMARA: a Web Dynamic Application Within a N-tier Architecture for Rare Diseases

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

SCIENCE COMMITTEE PROGRAMME FOUNDATION AWARDS OUTLINE APPLICATION GUIDELINES

Use of disease registries for benefitrisk evaluation of medicines: A regulatory perspective. DIA Europe April Basel, Switzerland

Indian Department of Science and Technology and European Members States and Associated States. within the New INDIGO Partnership Programme (NPP)

Transcription:

Electronic Health Records for research and Hospital management The "Assistance Publique - Hôpitaux de Paris" initiative Pr Philippe Lechat Clinical Research Department, St Louis Hospital, AP-HP, Paris Hospital Network Workshop, Brussels 9 February 2017

AP-HP data Warehouse : from healthcare to research AP-HP = Network of 39 Public Hospitals in and around Paris («Ile de France») More than 1 million hospitalised patients / year Linked to Several Universities and many Research institute teams (Inserm, CNRS, Institut Pasteur) 30% of medical research publications in France 2

Assistance Publique Hôpitaux de Paris (AP-HP) Paris and Ile de France 39 University Hospitals 3

AP-HP data-warehouse : from healthcare to research Progressive Implementation of a same format of Electronic Health Records (EHRs) for all hospitalised patients in the different hospitals of AP-HP Creation of one unique AP-HP data-warehouse linked to the common AP-HP EHR with administrative (only one patient identification number), clinical, biological, imaging, genetic and therapeutic data (medicines, surgical acts, medical device implementation etc ) Important potential for clinical research, hospital management and patient care improvement Multiple implications : Medical / para-medical / Scientific / financial hospital management / Hospital organisation and planification / Health care / medical research / teaching policy for medical students Requires «regulation» of access and use, professional cooperation, patients information and implication 4

AP-HP Data Warehouse Global Architecture Data-Warehouse Patient Health care data Biology Imaging data Xray Tomodensitometry MRI, PET scan Isotope imaging Anatomo-pathology Etc Patient identification Disease classification (IDC 10) codification 5

AP-HP data WareHouse : Which kind of database driven studies? Studies on hospital management (performed by medical information departments) : numbers of treated patients in a given IDC10 category, therapeutic acts codification, duration of hospitalisation, evaluation of ambulatory modes of hospital care, hospital costs, medicine use and costs etc Clinical research : Information on numbers of patients corresponding to a given set of characteristics : inclusion/ non inclusion criteria in a potential clinical trial (= «feasibility» studies on numbers of patients for a future recruitement in clinical trials) Research on patient healthcare AP-HP database (anonymous data with patient de-identification) Epidemiological, pharmaco-epidemiological, medico-economic studies on patient categories that are taken in charge in several medical departments and several (all) AP-HP hospitals («multicentric AP-HP» studies) 6

AP-HP data warehouse : Multicentric research One investigator (medical or paramedics) wishes to perform one study Facilitating staff : One data-warehouse coordinator for each hospital (or for a group of AP-HP hospitals) Clinical reasearch unit staff (methodologists, data-scientists) Medical information of all involved health care professionals with agreement of publication rules = non opposition rules (opt out) Submission to the Scientific and Ethical review Board (AP-HP Datawarehouse Institutional Review Board) 20 members (physicians, biologists, pharmacists, surgeons, pediatricians, paramedics, patient representatives etc ), one chairman and one co-chairman Scientific, Ethics and feasibility review of each submitted research protocole May play a «diplomatic» role in case of any conflictual situation on data use 7

Procedure for access to the AP-HP data Warehouse to external actors/partners Good opportunity to reinforce all interactions and links between Hospitals and University (double belonging University/Hospital for medical professors in France) Many potential suties will be promoted by external academic or non academic partners for AP-HP multicentric studies : Academic partners : Other public Hospitals, Institut national de la santé et de la recheche médicale (Inserm), Centre National pour la Recherche Scientifique (CNRS), Institut national pour la recherche (INRIA), Institut Pasteur, commissariat à l énergie atomique (CEA) etc... Patient associations, pharmaceutical companies Methodology : One corresponding AP-HP physician in charge of management of external demands (Clinical Research Department) Written contracts beween external partner and APH-HP (financial compensation for expertise and work that will have to be required for the study performance) 8

Patient information «non opposition» principle (opt-out) Information on patient leaflets that are given to hospitalised patients at hospital entry saying that their personal medical data can be potentially used for research (without possibility of patient identification for researchers) Information on a dedicated website providing the list of accepted research protocoles : Possibility will be offered to patients to prevent their personal medical data to be used for one given research protocol It will be investigated the possibility of obtaining a written consent (opt-in) in order to : Obtain an active support from patients to such medical research Facilitate scientific publications in some international journals that could request such written informed consent 9

Scientific and Ethics committee 20 members: Health care professionals (physicians, pharmacists, surgeons, pediatricians, paramedics, methodologists, biostatisticians, ethics, public health) + medico-economists + patient representatives (2) One chairman, one co-chairman Two hour Meeting every month (at beginning) Validation of information documents, submission templates, questions and answers documents, website update etc The committee will analyse every submitted research protocole on Scientific interest Ethical aspects Technical feasibility according to requested data to be studied in the data warehouse The committee will ask for additional expert opinion when necessary Will use accelerated analysis procedures for some specific procedures such as feasibility studies (number of patients according to some inclusion/non inclusion criteria of a planned clinical trial) First meeting held on 13th December 2016 10

Regulatory aspects and patient data protection rules (1) CNIL (commission Nationale Informatique et liberté) MR003 Reference methodology studies Publication in July 2016 by the french CNIL of a reference methodology (MR003) allowing non interventional researches on anonymous (with patient de-identification) data collected in databases Requires declaration and CNIL autorisation of the AP-HP Data-Warehouse Allows such researches to be performed without any further procedure if they fit with the limits and definition of the so called «MR003 CNIL Methodology» 11

Regulatory aspects and patient data protection rules (2) Non CNIL MR003 reference methodology studies Any personal (non anonymous) data used in the setting of vigilance studies (Pharmacovigilance, matériovigilance, cosmétovigilance, hémovigilance, biovigilance) Genetic investigations that aim at patient identification or re-identification by means of their genetic chracteristics Research requiring connexion with other administrative data-bases (SNIIRAM from Public health Insurance system - CNAMTS) Research requiring patient identification for longitudinal follow up 12

AP-HP data-warehouse State of the art and perspectives Planification of the common EHR for all AP-HP hospitals for 2017-2020 Data-Warehouse set up in all AP-HP hospitals for 2017-2018 Scientific and ethical datawarehouse (IRB) ready to start now when CNIL autorisation will be delivered Huge work of data structuration and data codification for valid clinical research (clinical data, biology, imaging data etc ) especially not only based on text analysis of patient hospitalisation reports ++ For medical research «Big data» has to mean «correct and reliable data» first!! ++ Big financial investment and AP-HP community input for such EHR and Data-Warehouse implementation («great excitment!») 13